Clinical observation of Qingyi granule combined with dexamethasone in the treatment of acute pancreatitis

Phase 1

Recruiting

• Conditions: acute pancreatitis associated lung injury

• Registration Number: ITMCTR2200006356
• Lead Sponsor: The First Affiliated Hospital of Dalian Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1)Acute pancreatitis patients who meet the diagnostic criteria for Atlanta; (2)Moderately severe acute pancreatitis (MSAP)or severe acute pancreatitis (Severe acute pancreatitis, SAP)patients, who meet one of the following three items is sufficient: (i)Acute Physiology and Chronic Health Assessment Form (APACHE-?)> 8 points(see attached table1); (ii)Ranson score> 3 points(see attached table2); (iii)Modified Marshall score = 2 points(see attached table3)(3)Age> 18 years old;

Exclusion Criteria

(1)Patients with severe heart, liver, and kidney diseases; (2)Patients with shock and cachexia; (3)Patients with recurrent acute pancreatitis; (4)Patients with previous hematopoietic system primary disease; (5)Patients with previous complications of rheumatic immune diseases or mental illness; (6)Pregnancy and puerperium; (7)Incomplete medical records;

Study & Design

• Study Type: Observational study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mortality rate;Incidence of ALI/ARDS;Incidence of pleural effusion;

Secondary Outcome Measures

Name	Time	Method
aboratory indicators:Amy\Lps\Tbil\ALT/AST\?-GT\ALP\WBC\Urea\CRE\Ca2+;Incidence of abnormal bowel sounds;Duration of abdominal pain and bloating after admission;ICU occupancy rate;Ventilator utilization;